Company Analysis

ResMed Inc. (RMD)

NYSE: RMD · Surgical & Medical Instruments & Apparatus · San Diego, CA · filing with the SEC since 1996
Grade6.8
◀ Past 6.9● Present 7.8▶ Future 5.4

Who runs ResMed Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Farrell Michael J.
Chairman and CEO. First filing Mar 2010, latest Nov 12, 2026, 81 filings in all.
Officers reporting now
6
of 16 people with a filing in the last fifteen months
Directors reporting now
10
29 people on the record since 2006
Officerssales are open-market, Nov 13, 2025 to Nov 13, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Rider Michael JGlobal General CounselJul 2023Nov 13, 20264 · $100,000
Farrell Michael J.Chairman and CEOMar 2010Nov 12, 202612 · $13.8M
Bloomer AaronChief Financial OfficerMay 2026Oct 1, 2026none
Leong JustinChief Product OfficerOct 2020Oct 1, 2026none
Farrell Peter CChairman of the BoardFeb 2006Sep 4, 20267 · $4.5M
Sandercock BrettChief Financial OfficerFeb 2006May 4, 20265 · $1.2M
Directorssales are open-market, Nov 13, 2025 to Nov 13, 2026
NameRoleFirst filingLatest filingSales, 12 months
Gill HarjitdirectorNov 2018Nov 13, 2026none
De Witte JandirectorMay 2019Nov 26, 20251 · $500,000
Mowad-Nassar NicoledirectorSep 2025Nov 26, 2025none
Burt CaroldirectorNov 2013Nov 24, 2025none
Delorefice ChristopherdirectorAug 2024Nov 24, 2025none
Drexler KarendirectorNov 2017Nov 24, 2025none
Hernandez JohndirectorNov 2021Nov 24, 2025none
Tan DesneydirectorNov 2021Nov 24, 2025none
Taylor Ronald RdirectorJul 2006Nov 24, 2025none
Sulpizio RicharddirectorJul 2006Nov 21, 2025none
Earlier names on the record13, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton RMD · research, not advice